These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 83712)

  • 1. Indications that Dw and DRw determinants are controlled by distinct (but closely linked) genes.
    Suciu-Foca N; Weiner J; Rohowsky C; McKiernan P; Susinno E; Rubinstein P
    Transplant Proc; 1978 Dec; 10(4):799-804. PubMed ID: 83712
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence that HLA-D is different from DR and that two different HLA loci code for B-cell antigens.
    Suciu-Foca N; Godfrey M; Rohowsky C; McKiernan P; Susinno E; Broell J
    Transplant Proc; 1979 Dec; 11(4):1781-7. PubMed ID: 93805
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenetic analysis of an unusual HLA region recombination by intrafamilial MLR, PLT, and CMC.
    Shaw S; O'Neill GJ; Shearer GM
    Transplant Proc; 1979 Dec; 11(4):1804-8. PubMed ID: 93809
    [No Abstract]   [Full Text] [Related]  

  • 4. The genetics of PLT response. II. HLA-DRw is a major PLT-stimulating determinant.
    DeWolf WC; Carroll PG; Mehta CR; Martin SL; Yunis EJ
    J Immunol; 1979 Jul; 123(1):37-42. PubMed ID: 87478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-D and DRw determinants in an American indigenous isolate.
    Layrisse Z; Simoney N; Park MS; Terasaki PI
    Transplant Proc; 1979 Dec; 11(4):1788-91. PubMed ID: 93806
    [No Abstract]   [Full Text] [Related]  

  • 6. Probable existence of four subloci in the HLA-DR (or D) region.
    Tsuji K; Nose Y; Komori K; Tajika R; Nakagawa M; Inouye H; Yamamura M
    Transplant Proc; 1979 Dec; 11(4):1792-5. PubMed ID: 161093
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison between HLA-D (LCL) and DR typing.
    Cohen-Miller B; Gatti RA; Leibold W
    Transplant Proc; 1979 Dec; 11(4):1796-8. PubMed ID: 93807
    [No Abstract]   [Full Text] [Related]  

  • 8. Two independent HLA-B-locus specificities expressed on a single haplotype.
    Danilovs JA; Terasaki PI; Kuban DJ; Sparkes RS; Gjertson D; Bernoco D
    Transplant Proc; 1979 Dec; 11(4):1722-5. PubMed ID: 93796
    [No Abstract]   [Full Text] [Related]  

  • 9. [HLA and leprosy].
    Demenais F; Feingold N
    Pathol Biol (Paris); 1986 Jun; 34(6):735-7. PubMed ID: 3531989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gene(s) controlling the synthesis of C1 esterase inhibitor is not linked to the genes of the HLA system and is not on the 6th chromosome.
    Goasguen J; Fauchet R; Guerin D; Genetet B; Brecy H; Ollier MP; Hartmann L
    Biomedicine; 1978 Nov; 29(7):248-52. PubMed ID: 747732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of HLA alloantigens of the Navajo Indians of North America. I. Variance of association between HLA-DRW (WIA) and HLA-DW specificities.
    Troup GM; Jameson J; Thomsen M; Svejgaard A; Walford RL
    Tissue Antigens; 1978 Jul; 12(1):44-57. PubMed ID: 80839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DRw determinants on human T cells primed against allogeneic lymphocytes.
    Suciu-Foca N; Susinno E; McKiernan P; Rohowsky C; Weiner J; Rubinstein P
    Transplant Proc; 1978 Dec; 10(4):845-8. PubMed ID: 83718
    [No Abstract]   [Full Text] [Related]  

  • 13. MHC specified lymphocyte activating and suppressor activating determinants in human mixed lymphocyte reactions.
    Fainboim L; Jaraquemada D; Festenstein H; Sachs JA
    Scand J Immunol; 1981 Dec; 14(6):655-67. PubMed ID: 6177031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA and infectious diseases.
    van Eden W; de Vries RR; van Rood JJ
    Prog Clin Biol Res; 1982; 103 Pt B():37-54. PubMed ID: 7163232
    [No Abstract]   [Full Text] [Related]  

  • 15. [11th International Histocompatibility Workshop 1991: Personal data for the Multiple Sclerosis Study].
    Wegener S; Falk U; Lakner K; Meyer-Riennecker HJ; Hauptmann G; Uring-Lambert B
    Beitr Infusionsther; 1992; 30():324-31. PubMed ID: 1284726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens.
    Parham P; Barnstable CJ; Bodmer WF
    J Immunol; 1979 Jul; 123(1):342-9. PubMed ID: 87477
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent developments in HLA typing.
    Duquesnoy RJ
    Prog Clin Biol Res; 1982; 88():125-42. PubMed ID: 6808523
    [No Abstract]   [Full Text] [Related]  

  • 18. CML target determinant segregating independently of HLA in an old-order Amish family.
    Hsu SH; Chan MM; Bias WB
    Transplant Proc; 1979 Dec; 11(4):1816-9. PubMed ID: 93810
    [No Abstract]   [Full Text] [Related]  

  • 19. Human cytotoxic T cell responses to trinitrophenyl hapten and influenza virus. Diversity of restriction antigens and specificity of HLA-linked genetic regulation.
    Biddison WE; Payne SM; Shearer GM; Shaw S
    J Exp Med; 1980 Aug; 152(2 Pt 2):204s-217s. PubMed ID: 6157766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetics of insulin-dependent juvenile diabetes].
    Raffoux C; Streiff F; Pointel JP; Debry G
    C R Seances Soc Biol Fil; 1980; 174(6):1077-83. PubMed ID: 6451269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.